FdaApplication
NDA 021434
Identifiers
- fda_app_no: NDA021434
Properties
| Property | Value |
|---|---|
| applicant_name | UPJOHN US 2 LLC |
| application_type | NDA |
| approval_date | 2003-01-17 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XANAX XR | ALPRAZOLAM | 0.5MG | TABLET, EXTENDED RELEASE;ORAL |
| XANAX XR | ALPRAZOLAM | 2MG | TABLET, EXTENDED RELEASE;ORAL |
| XANAX XR | ALPRAZOLAM | 1MG | TABLET, EXTENDED RELEASE;ORAL |
| XANAX XR | ALPRAZOLAM | 3MG | TABLET, EXTENDED RELEASE;ORAL |
4 products